Detalles de la búsqueda
1.
Frailty and Duration of Maintenance Dialysis: A Japanese Nationwide Cross-Sectional Study.
Am J Kidney Dis
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38876273
2.
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks.
Int J Urol
; 31(4): 422-429, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193573
3.
Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association.
Nephrol Dial Transplant
; 38(5): 1309-1317, 2023 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309475
4.
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD.
Nephrol Dial Transplant
; 2023 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37935473
5.
The uric acid-urea distribution volume ratio is a potential marker of hydration status in patients on hemodialysis.
J Artif Organs
; 26(4): 316-325, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36565326
6.
Body fluid volume calculated using the uric acid kinetic model relates to the vascular event.
J Artif Organs
; 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38079049
7.
Relationship between the fasting status during hospitalisation, the length of hospital stay and the outcome.
Br J Nutr
; 128(12): 2432-2437, 2022 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193721
8.
An investigation into possible sex differences in Association of Haemoglobin with survival among Haemodialysis patients in the J-DOPPS cohort.
Nephrology (Carlton)
; 27(10): 795-803, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442547
9.
Medical Director Practice of Advising Increased Dietary Protein Intake in Hemodialysis Patients With Hyperphosphatemia: Associations With Mortality in the Dialysis Outcomes and Practice Patterns Study.
J Ren Nutr
; 32(2): 243-250, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820694
10.
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
J Gastroenterol Hepatol
; 36(11): 3224-3232, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250635
11.
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus.
Kidney Blood Press Res
; 46(3): 352-361, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887741
12.
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities.
Clin Exp Nephrol
; 25(9): 996-1002, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057613
13.
Impact of visceral fat area in patients with chronic kidney disease.
Clin Exp Nephrol
; 25(6): 608-620, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595731
14.
Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.
Int J Clin Oncol
; 26(6): 1130-1138, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761026
15.
Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study.
Nephrology (Carlton)
; 26(1): 46-53, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32743932
16.
International variation in dialysis discontinuation in patients with advanced kidney disease.
CMAJ
; 192(35): E995-E1002, 2020 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868271
17.
Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.
Clin Exp Nephrol
; 24(2): 136-142, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641958
18.
A toolkit for ISN's registry initiative, SharE-RR.
Kidney Int
; 105(4): 646-648, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519226
19.
A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression.
Kidney Blood Press Res
; 44(3): 362-383, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31203292
20.
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Clin Exp Nephrol
; 28(2): 123-124, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070021